Advertisement
Loading...

Zoetis Inc.

ZTS•NYSE
Healthcare
Drug Manufacturers - General
$74.22
$-1.26(-1.67%)
U.S. Market opens in 27h 12m

Zoetis Inc. (ZTS) Stock Overview

Explore Zoetis Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap31.1B
P/E Ratio11.86
EPS (TTM)$6.10
ROE0.62%
Fundamental Analysis

AI Price Forecasts

1 Month$78.12
3 Months$105.63
1 Year Target$134.67

ZTS Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Zoetis Inc. (ZTS) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of A, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 13.39, suggesting the stock is in an oversold condition. Our forecasting models predict significant price movements, with a 12-month target of $134.67.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 11.86 and a market capitalization of 31.1B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-1.60%
5-Day Change
-14.95%
1-Month Change
-38.50%
3-Month Change
-41.36%
6-Month Change
-38.53%
Year-to-Date (YTD) Change
-40.97%
1-Year Change
-53.68%
3-Year Change
-59.60%
5-Year Change
-56.38%
All-Time (Max) Change
139.50%

Contact Information

https://www.zoetis.com
973 822 7000
10 Sylvan Way, Parsippany, NJ, 07054

Company Facts

13,800 Employees
IPO DateFeb 1, 2013
CountryUS
Actively Trading

Frequently Asked Questions